Literature DB >> 12111802

Insulin-like growth factor binding proteins-1 and -2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro.

Nicole M Kühl1, Jacques De Keyser, Hans De Vries, Dick Hoekstra.   

Abstract

Insulin-like growth factor-1 (IGF-1) is a growth and survival factor for oligodendrocyte lineage cells and induces myelination. Its actions are modulated by IGF binding proteins (IGFBPs) that are present in the extracellular fluids or on the cell surface. Additionally, IGFBPs are also known to exert actions that are independent of IGF-1. We studied whether IGF-binding proteins (IGFBPs)-1 and -2 modulate rat oligodendrocyte precursor (O2A) cell survival and differentiation in vitro both in the absence and presence of exogenously added IGF-1. The data reveal that IGFBP-1 and -2 reduced O2A cell survival in the absence and presence of exogenously added IGF-1. The effects of IGFBP-1 on cell survival in the presence of exogenously added IGF-1 were IGF-1-dependent, whereas IGFBP-2 displayed both IGF-1-dependent and IGF-1-independent effects. Furthermore, IGFBP-1 and -2 inhibited O2A cell differentiation in the presence of IGF-1 as reflected by decreased expression levels of two myelin proteins, CNPase (2',3'-cyclic nucleotide 3'-phosphohydrolase) and MAG (myelin associated glycoprotein). Analysis of medium samples revealed that O2A cells do not secrete proteases that degrade these IGFBPs. Taken together the data show that IGFBP-1 and -2 are negative effectors of oligodendrocyte survival and differentiation. Accordingly, the role of IGFBPs should be explicitly taken into account when investigating IGF-1 effects on oligodendrocytes, especially in the context of therapeutic purposes. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111802     DOI: 10.1002/jnr.10293

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

Review 1.  Stem cells for brain repair in neonatal hypoxia-ischemia.

Authors:  L Chicha; T Smith; R Guzman
Journal:  Childs Nerv Syst       Date:  2013-11-01       Impact factor: 1.475

2.  Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis.

Authors:  Cornelia Cudrici; Takahiro Ito; Ekaterina Zafranskaia; Susanna Weerth; Violeta Rus; Hegang Chen; Florin Niculescu; Katerina Soloviova; Cosmin Tegla; Adrian Gherman; Cedric S Raine; Moon L Shin; Horea Rus
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

3.  Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model.

Authors:  Victoria L M Herrera; Li Shen; Lyle V Lopez; Tamara Didishvili; You-Xun Zhang; Nelson Ruiz-Opazo
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

4.  Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate.

Authors:  Viktor Skihar; Claudia Silva; Andrew Chojnacki; Axinia Döring; William B Stallcup; Samuel Weiss; V Wee Yong
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-06       Impact factor: 11.205

5.  Adult-onset deficiency in growth hormone and insulin-like growth factor-I alters oligodendrocyte turnover in the corpus callosum.

Authors:  Kun Hua; M Elizabeth Forbes; Robin J Lichtenwalner; William E Sonntag; David R Riddle
Journal:  Glia       Date:  2009-08-01       Impact factor: 7.452

6.  Investigation of sequential growth factor delivery during cuprizone challenge in mice aimed to enhance oligodendrogliogenesis and myelin repair.

Authors:  Jennifer K Sabo; Tim D Aumann; Trevor J Kilpatrick; Holly S Cate
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

7.  Secretome Analysis of Mesenchymal Stem Cell Factors Fostering Oligodendroglial Differentiation of Neural Stem Cells In Vivo.

Authors:  Iria Samper Agrelo; Jessica Schira-Heinen; Felix Beyer; Janos Groh; Christine Bütermann; Veronica Estrada; Gereon Poschmann; Ana Bribian; Janusz J Jadasz; Laura Lopez-Mascaraque; David Kremer; Rudolf Martini; Hans Werner Müller; Hans Peter Hartung; James Adjaye; Kai Stühler; Patrick Küry
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.